Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

PLACENTAL ALPHA-1-MICROGLOBULIN (PAMG-1) - ANVISA Registration 10322250094

Access comprehensive regulatory information for PLACENTAL ALPHA-1-MICROGLOBULIN (PAMG-1) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10322250094 and manufactured by QIAGEN. The registration is held by QIAGEN BIOTECNOLOGIA BRASIL LTDA. with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 1 companies making the same product including QIAGEN, and 2 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
1 Competitors
2 Recent Registrations
10322250094
Registration Details
ANVISA Registration Number: 10322250094
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Device Details

Registration Details

10322250094

25351503175201933

01334250000120

Company Information

QIAGEN
United States of America
PT: ESTADOS UNIDOS DA AMÉRICA

Dates and Status

Nov 25, 2019

VIGENTE

09/18/2025 19:00:01

Companies Making Similar Products
Top companies providing products with the same technical name: "PLACENTAL ALPHA-1-MICROGLOBULIN (PAMG-1)"